Azione 6826 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Shanghai Haohai Biological Technology Co., Ltd.

Azioni

6826

CNE100001W69

Mercato chiuso - Hong Kong S.E.
Altri mercati azionari
 10:09:09 25/04/2024 		Variaz. 5gg Var. 1 gen.
40,15 HKD +0,63% Grafico intraday di Shanghai Haohai Biological Technology Co., Ltd. +3,21% -0,37%
11/03 L'utile di Shanghai Haohai per il 2023 sale grazie a maggiori entrate; le azioni salgono del 5% MT
23/02 Shanghai Haohai Biological Technology Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5%
Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shanghai Haohai Biological Forecasts Up to 138% Boost in 2023 Profit
Shanghai Haohai Biological Technology Co., Ltd. Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2023
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd. Announces Resignation of Guo Yongqing as Independent Non-Executive Director, Chairman of Audit Committee, Member of Remuneration and Appraisal Committee and Member of Nomination Committee
Haohai Biological Technology's Q3 Profit Rises 34%; Hong Kong Shares Jump 5%
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd. commences an Equity Buyback Plan for 1,538,461 shares, representing 0.9% for CNY 200 million, under the auhtorization approved on September 15, 2023.
Shanghai Haohai Biological Technology to See Rise in January-September Profit
Shanghai Haohai Biological Technology Co., Ltd. Provides Unaudited Consolidated Financial Guidance for the Nine Months Ended 30 September 2023
Shanghai Haohai Biological Technology's Profit Surges 188.9% in H1; Shares Up 3%
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Haohai Biological Technology Co., Ltd. authorizes a Buyback Plan.
Shanghai Haohai Biological to Buy Remaining Stake in Medical Aesthetics, Cosmetology Business
Shanghai Haohai Biological Technology Co., Ltd. entered into the equity transfer agreement to acquire 36.3636% stake in OHMK Medical Technology Co., Ltd. from Tianjin Huacan Enterprise Management Consulting Partnership, Shanghai Ermei Enterprise Management Consulting Partnership, Yuan Yibing, Lian Songyong and Chen Guangfei for approximately CNY 150 million.
Shanghai Haohai Biological Technology’s H1 Profit to See Up to 210% Boost
Shanghai Haohai Biological Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 6826
  4. Notizie Shanghai Haohai Biological Technology Co., Ltd.
  5. Altre lingue